BizVibe Announces Its List of the Best Oncology Pharmaceutical Companies for 2017 – Business Wire (press release)

Posted: August 31, 2017 at 2:44 am

LONDON–(BUSINESS WIRE)–Oncology drugs are seeing a sharp increase in demand as cancer rates rise worldwide and treatment becomes moreadvancedand readily available. Competition between oncology pharmaceutical companies is changing in response to consumer needs and market opportunities. Innovation is a majorfactorin this industry. Key vendors are focusing onthe development ofmultifunctional oncology drugs that offer increased patient comfort, better treatment, and improved patient outcomes forindividualsacross the world.

BizVibeis one of the largestb2bnetworks for drug manufacturing companies in the world, withover 330,000 buyers, suppliers, and manufacturers in the global pharmaceutical industry.

Network with the Top Oncology Pharmaceutical Companies

In a recent article titledTop 10 Oncology Drugs Companies,BizVibereveals 2017s top 10 Oncologypharmacompanies and the best-selling drugs that they are bringing to the market.

Top 10 Oncology Drugs Companies of 2017

10. Bristol-MeyersSquibb:BMShas a wide portfolio of oncology drugs. Its top-selling oncology drugs,ErbituxandYervoy, generated sales totaling USD 1.9 billion and USD 960 million respectively last year.

9. Eli Lilly:Of Lillys total USD 21 billion drug manufacturing revenue from last year, roughly USD 3.72 billionwas generatedfrom the companys oncology segment. Sales of its top-selling oncology drug,Almita, totaled USD 2.5 billion last year.

8. AstraZeneca:Much ofAstraZenecas revenueis generatedthrough the sale of oncology drugs, includingZoladex, whichis usedto treat prostate and breast cancers. Sales ofZoladexgenerate roughly USD 1 billion each year. AstraZeneca generated more than USD 23 billion in revenue last year.

7. AbbVie:In 2015,AbbVieacquiredPharmalytics, an oncology firm, and with it Pharmalyticss blood cancer treatment,ibrutinib. Global sales ofibrutinibwere projectedto beworth USD 1 billion in 2016.

6. Celgene:CelgenemanufacturesRevlimid, one of the best-selling oncology drugs in the world. It treats multiplemyeloma. Sales ofRevlimidtotal more than USD 4 billion annually.

Read the Entire Article Here

In addition to top oncologypharmacompanies,BizVibeis home to more than 7 million companies.UsingBizVibesplatform, users can generate leads, short list prospects, network with businesses from around the world, and trade seamlessly.TheBizVibeplatform allows you to discover the highest quality leads and make meaningful connections with companies of interest, all in real-time.Claim your company profile for freeand letBizVibeconnect you with potential business partners. To make things as simple as possible,use theBizVibeChatbot to create new business opportunities.

AboutBizVibe

The single-minded focus ofBizVibesplatform is to make networking easier. Over the years, we’ve searched far and wide to figure out how businesses connect and enable trade. That first interaction is usually fraught with the uncertainty of finding a potential partner vs. a potential nightmare. With this in mind, we’ve designed a robust set of tools to help companies generate leads, short list prospects, network with businesses from around the world and trade seamlessly.

BizVibeis headquartered in Toronto and has offices in London, Bangalore, and Beijing. For more information on theBizVibenetwork, pleasecontact us.

Excerpt from:
BizVibe Announces Its List of the Best Oncology Pharmaceutical Companies for 2017 – Business Wire (press release)

Related Post